{"database": "lobbying", "table": "lobbying_activities", "rows": [[1448343, "6a57783f-20a3-4c9d-b92e-3321aec538d6", "Q3", "EMERGENT BIOSOLUTIONS INC.", 304931, "EMERGENT BIOSOLUTIONS INC", 2013, "third_quarter", "DIS", "HR 2217, Department of Homeland Security Appropriations Act, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines;\nDraft Fiscal Year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations bill, provisions related to the development, acquisition and stockpiling of biodefense vaccines;HJ Res. 59 - Continuing Appropriations Resolution, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines.", "HOUSE OF REPRESENTATIVES,SENATE", null, 640000, 0, 0, "2013-10-17T16:23:44.793000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1448343"], "units": {}, "query_ms": 0.3744830028153956, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}